The New York and Presbyterian Hospital

The New York and Presbyterian Hospital was paid $454.95M by Medicaid between Jan 2018 and Dec 2024, across 1005 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 14% of everything it billed.

33Billing provider infoTHE NEW YORK AND PRESBYTERIAN HOSPITAL
NEW YORK, NY 10032

33aNPI1194832477assigned 08/24/2006

33bProvider typeCase Management Agency

28Total paid$454.95M

24GClaims7,110,407

24DCodes billed1005

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Case Management Agency providers in New York

Rank by total paid#3 of 180

Median peer was paid$1.76M

This provider vs. median258×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	181,955	$10.28M
2019	492,022	$32.59M
2020	1,026,541	$63.63M
2021	1,342,691	$85.12M
2022	1,404,401	$92.27M
2023	1,459,265	$97.76M
2024incomplete	1,203,532	$73.29M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	14%	343,159	289,761	$65.07M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.9%	172,115	159,539	$31.49M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	5.2%	132,346	126,711	$23.63M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	4.7%	117,884	107,210	$21.33M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	3.3%	91,521	87,526	$15.12M
G9005	Coordinated care fee, risk adjusted maintenance	2.9%	42,846	42,266	$13.16M
96361	Intravenous infusion, hydration; each additional hour	2.8%	43,901	40,573	$12.73M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	2.7%	65,594	55,404	$12.47M
T1016	Case management, each 15 minutes	2.2%	42,778	42,778	$9.91M
J9271	Injection, pembrolizumab, 1 mg	2.0%	1,121	912	$8.98M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.6%	2,733	2,460	$7.11M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	1.4%	33,934	31,615	$6.22M

993 more codes

92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	1.2%	43,990	$5.41M
76700	Ultrasound, abdominal, real time with image documentation; complete	1.2%	9,155	$5.35M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	1.1%	3,297	$5.15M
90834	Psychotherapy session, about 45 minutes	1.1%	27,024	$5.05M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	1.0%	26,451	$4.77M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.0%	7,363	$4.76M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	63,491	$4.44M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	31,175	$4.14M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	22,556	$4.13M
70450	Computed tomography, head or brain; without contrast material	<1%	14,983	$4.02M
90832	Psychotherapy session, about 30 minutes	<1%	25,575	$3.80M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	5,633	$3.75M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	23,183	$3.65M
96415		<1%	6,461	$3.62M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	4,505	$3.53M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	37,495	$3.45M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	17,787	$3.21M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	12,165	$3.16M
80048	Basic metabolic panel (calcium, ionized)	<1%	216,040	$3.06M
80076		<1%	138,727	$2.79M
J2505	Injection, pegfilgrastim, 6 mg	<1%	1,000	$2.72M
99215	Doctor's office visit, returning patient (complex)	<1%	14,021	$2.59M
93505		<1%	1,407	$2.55M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	86,745	$2.43M
87486		<1%	65,655	$2.43M
J0485	Injection, belatacept, 1 mg	<1%	3,468	$2.19M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	87,273	$2.14M
J9312	Injection, rituximab, 10 mg	<1%	470	$2.13M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	15,467	$2.09M
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	11,426	$1.99M
90791	Psychiatric diagnostic evaluation	<1%	4,428	$1.86M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	6,959	$1.73M
86850		<1%	37,859	$1.72M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,221	$1.69M
76770		<1%	4,354	$1.68M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	916	$1.67M
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	<1%	1,007	$1.59M
36415	Collection of venous blood by venipuncture	<1%	310,693	$1.54M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	930	$1.52M
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	68,021	$1.32M
77336		<1%	3,004	$1.30M
86901		<1%	45,151	$1.30M
59025	Fetal non-stress test	<1%	4,911	$1.30M
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	1,468	$1.28M
87581		<1%	65,601	$1.26M
93970		<1%	2,219	$1.25M
D0999	Unspecified diagnostic procedure, by report	<1%	11,374	$1.24M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	14,521	$1.24M
86480		<1%	18,027	$1.23M
47562		<1%	424	$1.21M
77412		<1%	4,006	$1.16M
86900		<1%	45,614	$1.13M
80061	Lipid panel	<1%	50,865	$1.11M
90846	Family psychotherapy without the patient present, 50 minutes	<1%	7,394	$1.10M
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	1,092	$1.09M
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	766	$1.04M
36430		<1%	2,920	$1.04M
12001		<1%	2,040	$1.04M
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	2,438	$1.03M
12011		<1%	1,919	$1.01M
80053	Comprehensive metabolic panel	<1%	52,561	$1.00M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	39,369	$988K
90651		<1%	11,114	$978K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	3,499	$953K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	1,161	$946K
72197		<1%	1,968	$944K
90686		<1%	50,400	$944K
96416		<1%	1,452	$929K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	1,051	$896K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	12,472	$893K
J2350	Injection, ocrelizumab, 1 mg	<1%	50	$873K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	3,418	$868K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	4,085	$858K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	612	$835K
93458		<1%	549	$826K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	20,139	$817K
97161		<1%	5,118	$803K
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	267	$797K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	1,721	$782K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	22,064	$777K
44970		<1%	246	$728K
49650		<1%	283	$728K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	7,708	$715K
10060		<1%	1,939	$710K
0002A		<1%	18,733	$703K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	8,969	$697K
0001A		<1%	20,472	$650K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	22,209	$644K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	3,661	$642K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,376	$642K
87536		<1%	11,427	$623K
90837	Psychotherapy session, about an hour	<1%	3,215	$609K
90715		<1%	24,131	$608K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	22,273	$608K
97802		<1%	13,064	$605K
J9306	Injection, pertuzumab, 1 mg	<1%	119	$586K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	4,642	$577K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	683	$575K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	18,751	$564K
19083		<1%	353	$563K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,648	$558K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	3,320	$536K
96367		<1%	4,703	$519K
99243		<1%	2,498	$517K
77334		<1%	1,391	$496K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	43,661	$496K
97803		<1%	11,339	$495K
83880		<1%	18,218	$483K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	9,004	$478K
54161		<1%	470	$476K
43235		<1%	593	$473K
99205	Prolong outpt/office vis	<1%	2,695	$473K
88342		<1%	8,306	$473K
11982		<1%	1,188	$467K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	11,713	$455K
11981		<1%	1,088	$435K
74183		<1%	2,450	$430K
J1726	Injection, hydroxyprogesterone caproate, (makena), 10 mg	<1%	1,056	$421K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	13,579	$406K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,364	$405K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	235	$404K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	9,469	$402K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	32,094	$398K
58100		<1%	662	$396K
87799		<1%	13,402	$388K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	59,012	$388K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	5,106	$382K
83655		<1%	25,953	$378K
52356		<1%	169	$373K
12002		<1%	714	$372K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	836	$371K
85610		<1%	73,543	$364K
94375		<1%	3,315	$363K
90677		<1%	5,835	$356K
70496		<1%	1,258	$353K
96910		<1%	4,121	$345K
93454		<1%	219	$343K
58300		<1%	2,008	$333K
J9035	Injection, bevacizumab, 10 mg	<1%	97	$331K
82803		<1%	16,972	$330K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	899	$326K
11900		<1%	990	$324K
71250		<1%	2,657	$314K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	649	$312K
93451		<1%	156	$311K
88307		<1%	4,388	$307K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	101	$299K
88184		<1%	3,889	$292K
77386		<1%	1,736	$290K
93460		<1%	154	$286K
J0185	Injection, aprepitant, 1 mg	<1%	3,363	$285K
J3490	Unclassified drugs	<1%	2,892	$285K
OP370		<1%	725	$283K
77300		<1%	1,268	$280K
97162		<1%	1,599	$279K
71046	Radiologic examination, chest; 2 views	<1%	49,863	$279K
OP710		<1%	1,223	$276K
90882		<1%	3,071	$270K
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	202	$264K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	3,840	$264K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	6,525	$264K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	383	$263K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	765	$262K
85055		<1%	7,304	$260K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,831	$256K
94060		<1%	1,258	$254K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	2,243	$252K
96375	Therapeutic injection; each additional sequential IV push	<1%	45,353	$247K
85027		<1%	87,621	$242K
90792	Psychiatric diagnostic evaluation with medical services	<1%	1,123	$242K
J7300	Intrauterine copper contraceptive (paragard)	<1%	528	$241K
58301		<1%	1,557	$240K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	197,818	$236K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	89,861	$236K
97166		<1%	1,271	$234K
92526		<1%	1,699	$232K
97535	Self-care/home management training, each 15 minutes	<1%	2,893	$231K
80047		<1%	14,090	$229K
93971		<1%	3,629	$228K
87507		<1%	3,480	$227K
93975		<1%	808	$225K
J9299	Injection, nivolumab, 1 mg	<1%	49	$220K
90750		<1%	2,526	$218K
74178		<1%	1,289	$217K
92611		<1%	795	$212K
J9070	Cyclophosphamide, 100 mg	<1%	933	$211K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	69	$211K
92551		<1%	2,730	$210K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	896	$207K
J0897	Injection, denosumab, 1 mg	<1%	259	$203K
90670		<1%	18,614	$203K
76000		<1%	2,508	$200K
86356		<1%	6,275	$199K
70486		<1%	2,177	$195K
96409		<1%	2,775	$192K
42830		<1%	98	$190K
87517		<1%	5,074	$189K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	13,552	$189K
72192		<1%	766	$188K
58661		<1%	72	$186K
99382		<1%	945	$185K
70491		<1%	692	$182K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	727	$182K
76999		<1%	2,120	$181K
99443		<1%	2,536	$180K
81003		<1%	154,261	$179K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	875	$179K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	237	$178K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	1,265	$178K
36416		<1%	9,588	$177K
94726		<1%	1,201	$176K
90674		<1%	4,969	$175K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	1,119	$174K
86703		<1%	11,847	$171K
99381		<1%	1,037	$169K
90378		<1%	57	$162K
92610		<1%	1,085	$161K
72141		<1%	644	$161K
58558		<1%	118	$160K
97165		<1%	1,144	$159K
83970		<1%	5,444	$157K
71275	Computed tomographic angiography, chest, with contrast material	<1%	610	$156K
90697		<1%	5,940	$155K
84703		<1%	90,907	$154K
31624		<1%	166	$149K
36591		<1%	2,322	$146K
86360		<1%	9,755	$145K
76870		<1%	2,184	$145K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	49,516	$143K
C1776	Joint device (implantable)	<1%	136	$141K
C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	<1%	60	$140K
99188		<1%	2,323	$140K
96417		<1%	4,944	$140K
91322		<1%	1,938	$139K
77065	Tomosynthesis, mammo	<1%	1,781	$139K
76937		<1%	807	$138K
76801		<1%	953	$137K
83021		<1%	9,939	$136K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,543	$136K
84443	Thyroid stimulating hormone (TSH)	<1%	48,263	$136K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	790	$133K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	1,995	$133K
90681		<1%	12,379	$132K
83036	Hemoglobin; glycosylated (A1C)	<1%	66,532	$131K
88304		<1%	4,576	$129K
99442		<1%	3,295	$126K
90647		<1%	13,783	$126K
88341		<1%	3,825	$126K
97116		<1%	2,642	$125K
76830	Ultrasound, transvaginal	<1%	5,541	$124K
92557		<1%	1,993	$119K
86832		<1%	1,658	$119K
J0178	Injection, aflibercept, 1 mg	<1%	228	$117K
0003A		<1%	3,113	$116K
86359		<1%	9,733	$116K
77280		<1%	263	$116K
93017		<1%	765	$116K
J0490	Injection, belimumab, 10 mg	<1%	70	$116K
76819	Fetal biophysical profile; without non-stress testing	<1%	1,555	$115K
86355		<1%	9,730	$114K
86357		<1%	9,730	$114K
77290		<1%	306	$112K
71045	Radiologic examination, chest; single view	<1%	12,770	$112K
92550		<1%	2,221	$110K
90723		<1%	12,661	$108K
86833		<1%	1,848	$108K
94618		<1%	588	$106K
0124A		<1%	2,901	$106K
90836		<1%	965	$105K
99383		<1%	529	$105K
93304		<1%	361	$102K
74230		<1%	428	$102K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,354	$101K
17110		<1%	283	$101K
73221		<1%	317	$100K
76642		<1%	1,434	$98K
92978		<1%	378	$98K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	5,230	$98K
87653		<1%	4,475	$97K
Q5123	Injection, rituximab-arrx, biosimilar, (riabni), 10 mg	<1%	46	$96K
83735		<1%	49,475	$95K
96402		<1%	1,598	$95K
90716		<1%	6,346	$91K
96401		<1%	1,904	$91K
87529		<1%	4,438	$90K
93320		<1%	338	$90K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	46,681	$90K
92579		<1%	1,053	$90K
90707		<1%	6,743	$89K
J1750	Injection, iron dextran, 50 mg	<1%	571	$88K
96377		<1%	1,786	$87K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	430	$85K
96450		<1%	110	$83K
92567		<1%	1,186	$83K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	113	$83K
99173		<1%	2,817	$82K
94621		<1%	420	$82K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	793	$79K
90633		<1%	9,554	$78K
96411		<1%	2,589	$77K
C1769	Guide wire	<1%	7,246	$76K
76942		<1%	609	$76K
86352		<1%	1,204	$76K
99384		<1%	392	$74K
82728		<1%	22,680	$74K
86803		<1%	31,950	$74K
64615		<1%	184	$71K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	2,504	$70K
94010		<1%	878	$70K
0072A		<1%	1,687	$68K
86923		<1%	3,360	$67K
85045		<1%	12,385	$66K
90656		<1%	5,746	$65K
94729		<1%	2,799	$64K
80197		<1%	10,218	$64K
90734		<1%	5,685	$64K
0071A		<1%	1,553	$63K
11104		<1%	96	$63K
72082		<1%	3,303	$61K
88112		<1%	1,243	$61K
82784		<1%	11,101	$60K
J1453	Injection, fosaprepitant, 1 mg	<1%	386	$60K
99408		<1%	542	$58K
C1753	Catheter, intravascular ultrasound	<1%	494	$57K
93270		<1%	280	$57K
93325		<1%	924	$56K
84100		<1%	36,998	$56K
86828		<1%	3,047	$55K
99407		<1%	519	$55K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	5,339	$55K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	359	$54K
77338		<1%	186	$54K
76857		<1%	1,854	$54K
86592		<1%	51,316	$54K
A9585	Injection, gadobutrol, 0.1 ml	<1%	7,544	$53K
87497		<1%	3,165	$53K
90700		<1%	5,197	$53K
90732		<1%	1,579	$52K
90620		<1%	1,954	$52K
76536		<1%	1,014	$52K
OP272		<1%	1,006	$52K
99385		<1%	315	$52K
86141		<1%	21,521	$51K
84702		<1%	24,207	$49K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	1,254	$49K
97542		<1%	450	$49K
C1874	Stent, coated/covered, with delivery system	<1%	202	$48K
90461		<1%	5,143	$47K
86317		<1%	7,841	$47K
OP270		<1%	828	$46K
72158		<1%	163	$46K
90696		<1%	4,111	$46K
90746		<1%	1,550	$46K
76881		<1%	323	$46K
84439		<1%	11,668	$45K
85730		<1%	33,176	$45K
90710		<1%	4,155	$44K
81025		<1%	8,039	$43K
77295		<1%	288	$43K
93308		<1%	189	$42K
93456		<1%	26	$42K
0054A		<1%	1,188	$42K
82607		<1%	12,200	$41K
77332		<1%	98	$41K
J3262	Injection, tocilizumab, 1 mg	<1%	65	$41K
92002		<1%	327	$40K
87522	Neg quan hep c or qual rna	<1%	1,249	$40K
70543		<1%	87	$40K
87496		<1%	2,097	$40K
77072		<1%	2,020	$39K
G9001	Coordinated care fee, initial rate	<1%	523	$39K
70544		<1%	283	$39K
87086	Culture, bacterial; quantitative colony count, urine	<1%	48,634	$38K
77066	Tomosynthesis, mammo	<1%	586	$38K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	39,552	$38K
83615		<1%	17,861	$38K
84484		<1%	52,103	$38K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	3,821	$38K
99245		<1%	169	$38K
D1110	Prophylaxis - adult	<1%	1,805	$36K
27447		<1%	12	$36K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	22,650	$35K
81001		<1%	53,086	$35K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	1,001	$35K
88346		<1%	809	$34K
73564		<1%	3,016	$34K
86807		<1%	2,043	$33K
87340		<1%	22,429	$33K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	666	$33K
90480		<1%	1,976	$33K
96376		<1%	7,978	$33K
77049		<1%	82	$32K
73700		<1%	174	$32K
54150		<1%	30	$32K
99441		<1%	1,181	$32K
74240		<1%	129	$32K
83516		<1%	3,608	$32K
96900		<1%	329	$31K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	4,216	$31K
C1781	Mesh (implantable)	<1%	542	$31K
71555		<1%	93	$31K
11976		<1%	50	$30K
86821		<1%	651	$30K
76098		<1%	201	$30K
88185		<1%	344	$30K
67028	Intravitreal injection of a pharmacologic agent	<1%	442	$29K
47563		<1%	12	$29K
90381		<1%	443	$29K
85018		<1%	13,017	$29K
91320		<1%	543	$28K
88360		<1%	346	$28K
76825		<1%	303	$28K
84550		<1%	14,213	$28K
3E033GC		<1%	118	$28K
J7030	Infusion, normal saline solution , 1000 cc	<1%	17,222	$28K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	173	$28K
73630		<1%	7,716	$28K
92555		<1%	288	$27K
82670		<1%	2,006	$27K
75561		<1%	66	$27K
84403		<1%	3,195	$27K
73030		<1%	7,327	$27K
83540		<1%	18,590	$26K
83550		<1%	17,256	$26K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	210	$26K
J2997	Injection, alteplase recombinant, 1 mg	<1%	140	$26K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,277	$26K
84165		<1%	2,737	$26K
82805		<1%	1,078	$26K
90619		<1%	851	$25K
J9045	Injection, carboplatin, 50 mg	<1%	1,367	$25K
Q3014	Telehealth originating site facility fee	<1%	5,749	$25K
25605		<1%	50	$25K
86769		<1%	1,607	$25K
70498		<1%	1,122	$24K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	670	$24K
92015	Determination of refractive state	<1%	491	$24K
90634		<1%	1,863	$24K
C1819	Surgical tissue localization and excision device (implantable)	<1%	421	$24K
J9267	Injection, paclitaxel, 1 mg	<1%	1,530	$24K
92650		<1%	256	$23K
88312		<1%	1,387	$23K
82570		<1%	11,597	$23K
OP250		<1%	3,754	$22K
86765		<1%	12,535	$22K
83001		<1%	3,801	$22K
86762		<1%	12,694	$22K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	27	$22K
88262		<1%	199	$22K
92582		<1%	285	$22K
V2632	Posterior chamber intraocular lens	<1%	421	$22K
88142		<1%	719	$21K
72110		<1%	2,709	$21K
J7050	Infusion, normal saline solution, 250 cc	<1%	31,274	$21K
91318		<1%	624	$21K
84145		<1%	3,856	$21K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	374	$20K
73610		<1%	8,047	$20K
77301		<1%	145	$20K
52332		<1%	13	$20K
J3489	Injection, zoledronic acid, 1 mg	<1%	473	$20K
92568		<1%	194	$19K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	25	$19K
90672		<1%	1,273	$19K
J9190	Injection, fluorouracil, 500 mg	<1%	1,464	$18K
83002		<1%	2,534	$18K
J8540	Dexamethasone, oral, 0.25 mg	<1%	9,400	$18K
73080		<1%	3,543	$18K
73200		<1%	80	$18K
90662		<1%	1,981	$18K
58662		<1%	12	$18K
20680		<1%	12	$18K
86160		<1%	3,995	$18K
72156		<1%	69	$17K
91319		<1%	537	$17K
57455		<1%	26	$17K
76641		<1%	230	$17K
88365		<1%	268	$17K
J1756	Injection, iron sucrose, 1 mg	<1%	366	$17K
73521		<1%	2,156	$17K
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	<1%	17	$17K
87040		<1%	10,932	$17K
86787		<1%	9,628	$17K
85652		<1%	16,973	$17K
76982		<1%	61	$17K
84146		<1%	3,675	$16K
86335		<1%	1,050	$16K
77073		<1%	1,182	$16K
0081A		<1%	407	$16K
99242		<1%	78	$16K
31575		<1%	70	$16K
24640		<1%	35	$16K
86735		<1%	5,767	$16K
0154A		<1%	446	$16K
84153		<1%	3,389	$16K
91010		<1%	27	$16K
82962		<1%	49,724	$16K
83605		<1%	19,314	$16K
90849		<1%	217	$15K
70487		<1%	50	$15K
0052A		<1%	383	$15K
94150		<1%	361	$15K
82977		<1%	5,396	$15K
73110		<1%	5,801	$14K
57454		<1%	29	$14K
90694		<1%	1,838	$14K
82746		<1%	4,553	$14K
84207		<1%	777	$14K
83690		<1%	38,870	$14K
72131		<1%	111	$14K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	12,106	$14K
12013		<1%	24	$13K
82950		<1%	10,000	$13K
73560		<1%	5,270	$13K
97760		<1%	121	$13K
84480		<1%	4,172	$13K
72157		<1%	44	$13K
78306		<1%	278	$13K
73562		<1%	4,260	$13K
76818		<1%	342	$12K
84156		<1%	9,902	$12K
45331		<1%	13	$12K
86870		<1%	296	$12K
82043		<1%	10,028	$12K
86704		<1%	6,388	$12K
64643		<1%	24	$12K
82820		<1%	480	$12K
82378		<1%	3,107	$12K
87102		<1%	12,821	$12K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	88	$12K
0082A		<1%	290	$11K
90472	Immunization administration, each additional vaccine (list separately)	<1%	7,379	$11K
J9206	Injection, irinotecan, 20 mg	<1%	494	$11K
86235		<1%	1,781	$11K
86665		<1%	2,211	$11K
88271		<1%	324	$11K
99429		<1%	2,143	$11K
76813		<1%	163	$11K
86147		<1%	752	$11K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	17,263	$11K
72100		<1%	3,273	$11K
92134		<1%	116	$11K
0064A		<1%	329	$11K
82105		<1%	2,910	$11K
85379		<1%	7,243	$11K
0051A		<1%	276	$11K
73620		<1%	719	$10K
82533		<1%	1,414	$10K
J2704	Injection, propofol, 10 mg	<1%	41,887	$10K
72170		<1%	2,881	$10K
31628		<1%	54	$10K
90649		<1%	220	$10K
J0690	Injection, cefazolin sodium, 500 mg	<1%	11,365	$10K
47000		<1%	14	$10K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	9,065	$10K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	596	$10K
83020		<1%	1,203	$10K
83883		<1%	3,458	$10K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	341	$10K
82610		<1%	1,889	$10K
87205		<1%	22,088	$10K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	373	$10K
73130		<1%	5,976	$10K
82330		<1%	8,136	$9K
74221		<1%	40	$9K
73502		<1%	3,046	$9K
87088		<1%	9,665	$9K
96368		<1%	1,091	$9K
76885		<1%	77	$9K
80329		<1%	2,160	$9K
J9370	Vincristine sulfate, 1 mg	<1%	1,204	$9K
73120		<1%	1,246	$9K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	3,364	$9K
87070		<1%	9,430	$9K
82810		<1%	2,930	$9K
70480		<1%	42	$9K
88300		<1%	2,199	$9K
86300		<1%	1,760	$9K
87186		<1%	11,938	$9K
G0424	Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day	<1%	80	$8K
73590		<1%	3,731	$8K
84402		<1%	1,311	$8K
73090		<1%	3,032	$8K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	7,871	$8K
88344		<1%	124	$8K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	24,856	$8K
0173A		<1%	230	$8K
90714		<1%	389	$8K
93225		<1%	42	$8K
82550		<1%	6,390	$7K
84305		<1%	406	$7K
C1760	Closure device, vascular (implantable/insertable)	<1%	380	$7K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	2,730	$7K
0074A		<1%	183	$7K
D0120	Dental checkup, returning patient	<1%	5,070	$7K
88364		<1%	107	$7K
J9171	Injection, docetaxel, 1 mg	<1%	167	$7K
82248		<1%	4,862	$7K
72146		<1%	47	$7K
83520		<1%	1,014	$7K
96136		<1%	37	$7K
86003		<1%	488	$7K
86225		<1%	1,681	$7K
36593		<1%	45	$7K
82652		<1%	252	$7K
64644		<1%	25	$7K
93321		<1%	488	$7K
83498		<1%	482	$7K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	11,918	$7K
H2011	Crisis intervention service, per 15 minutes	<1%	46	$6K
88311		<1%	1,090	$6K
86708		<1%	2,324	$6K
84446		<1%	844	$6K
29125		<1%	24	$6K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	9,864	$6K
88720		<1%	1,469	$6K
82024		<1%	183	$6K
90380		<1%	183	$6K
86780		<1%	2,826	$6K
87641		<1%	252	$6K
86580		<1%	1,377	$6K
90744		<1%	558	$6K
86038		<1%	3,218	$6K
82627		<1%	894	$6K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	28	$6K
88274		<1%	62	$6K
86334		<1%	1,617	$6K
96523		<1%	80	$6K
87535		<1%	1,088	$6K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	687	$6K
84590		<1%	1,016	$6K
D1351	Sealant - per tooth	<1%	202	$6K
51702		<1%	12	$6K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	209	$6K
0134A		<1%	140	$6K
84704		<1%	823	$6K
84163		<1%	823	$5K
74018		<1%	1,966	$5K
84425		<1%	1,264	$5K
86812		<1%	55	$5K
75557		<1%	12	$5K
80195		<1%	811	$5K
84436		<1%	2,793	$5K
57456		<1%	13	$5K
90691		<1%	151	$5K
88302		<1%	539	$5K
J1437	Injection, ferric derisomaltose, 10 mg	<1%	12	$5K
86644		<1%	1,156	$5K
86376		<1%	944	$5K
73000		<1%	716	$5K
85245		<1%	166	$5K
73140		<1%	2,924	$5K
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	39	$5K
85384		<1%	1,855	$5K
72040		<1%	1,171	$5K
87081		<1%	5,105	$5K
80158		<1%	567	$5K
D0150	Comprehensive oral evaluation - new or established patient	<1%	239	$5K
73552		<1%	1,741	$5K
90476		<1%	285	$5K
86694		<1%	1,070	$5K
73060		<1%	1,693	$5K
57452		<1%	14	$5K
82947		<1%	7,746	$5K
87181		<1%	6,354	$5K
0296T		<1%	78	$4K
82088		<1%	134	$4K
88313		<1%	631	$4K
80320		<1%	6,857	$4K
86593		<1%	2,881	$4K
99241		<1%	26	$4K
17000		<1%	26	$4K
88237		<1%	42	$4K
90611		<1%	256	$4K
82525		<1%	516	$4K
D7140	Extraction, erupted tooth or exposed root	<1%	56	$4K
0053A		<1%	107	$4K
84460		<1%	6,744	$4K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	40,943	$4K
90685		<1%	226	$4K
87631		<1%	60	$4K
80069		<1%	401	$4K
84481		<1%	1,235	$4K
84630		<1%	1,044	$4K
86200		<1%	863	$4K
84450		<1%	2,047	$4K
86800		<1%	719	$4K
80180		<1%	421	$4K
72050		<1%	261	$4K
74455		<1%	12	$4K
86696		<1%	1,153	$4K
86431		<1%	1,764	$4K
74246		<1%	12	$3K
88235		<1%	26	$3K
82951		<1%	415	$3K
73600		<1%	683	$3K
72070		<1%	893	$3K
72052		<1%	278	$3K
74019		<1%	1,553	$3K
0012A		<1%	116	$3K
85347		<1%	2,472	$3K
88275		<1%	26	$3K
82565		<1%	4,501	$3K
90660		<1%	212	$3K
82657		<1%	566	$3K
86645		<1%	648	$3K
77062		<1%	45	$3K
86695		<1%	932	$3K
85014		<1%	16,435	$3K
82150		<1%	2,077	$3K
86945		<1%	69	$3K
Q0139	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)	<1%	16	$3K
76506		<1%	12	$3K
51798		<1%	12	$3K
76827		<1%	118	$3K
89051		<1%	1,463	$3K
87077		<1%	6,375	$3K
82785		<1%	495	$3K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,781	$2K
81002		<1%	10,236	$2K
90653		<1%	593	$2K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	15	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	34,812	$2K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	10,166	$2K
83010		<1%	980	$2K
75574		<1%	12	$2K
80162		<1%	309	$2K
G0008	Administration of influenza virus vaccine	<1%	2,909	$2K
83921		<1%	250	$2K
88280		<1%	134	$2K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,997	$2K
87593		<1%	125	$2K
0011A		<1%	109	$2K
36592		<1%	27	$2K
92585		<1%	13	$2K
87338		<1%	902	$2K
92588		<1%	24	$2K
83525		<1%	173	$2K
86304		<1%	932	$2K
90682		<1%	69	$2K
86880		<1%	67	$2K
86777		<1%	395	$2K
84681		<1%	229	$2K
71101		<1%	1,124	$2K
85246		<1%	73	$2K
80299		<1%	306	$2K
86146		<1%	423	$2K
C1726	Catheter, balloon dilatation, non-vascular	<1%	39	$2K
72114		<1%	81	$2K
82157		<1%	113	$2K
92626		<1%	92	$2K
84445		<1%	42	$2K
73100		<1%	414	$2K
86709		<1%	424	$2K
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	<1%	108	$2K
87116		<1%	1,024	$2K
96137		<1%	20	$2K
82085		<1%	131	$2K
80177		<1%	616	$2K
90739		<1%	41	$2K
85660		<1%	1,236	$2K
90713		<1%	142	$2K
J2785	Injection, regadenoson, 0.1 mg	<1%	297	$1K
80164		<1%	897	$1K
83090		<1%	122	$1K
92587		<1%	12	$1K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	176	$1K
74220		<1%	107	$1K
D0140	Limited oral evaluation - problem focused	<1%	361	$1K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	45,291	$1K
71271		<1%	13	$1K
83519		<1%	69	$1K
73070		<1%	764	$1K
90678		<1%	74	$1K
74174		<1%	26	$1K
87206		<1%	1,616	$1K
81268		<1%	51	$1K
94727		<1%	76	$1K
85651		<1%	1,722	$1K
87210		<1%	873	$1K
J1815	Injection, insulin, per 5 units	<1%	1,161	$1K
82677		<1%	331	$1K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,225	$1K
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	12	$1K
92652		<1%	14	$1K
95117		<1%	35	$1K
71270		<1%	37	$1K
0083A		<1%	29	$1K
99493		<1%	12	$1K
G0009	Administration of pneumococcal vaccine	<1%	674	$1K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	1,431	$1K
84270		<1%	80	$1K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	71	$1K
80179		<1%	1,506	$1K
91312		<1%	165	$1K
85613		<1%	165	$1K
73660		<1%	524	$1K
86140		<1%	1,774	$1K
90661		<1%	83	$991.96
74021		<1%	1,218	$979.80
J1729	Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg	<1%	14	$953.50
82239		<1%	534	$947.80
87184		<1%	980	$931.02
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	12,621	$927.02
C1758	Catheter, ureteral	<1%	244	$921.62
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	3,483	$889.83
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	87	$869.54
84132		<1%	3,421	$865.14
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	20,189	$852.68
J2270	Injection, morphine sulfate, up to 10 mg	<1%	7,325	$849.33
86039		<1%	290	$847.65
82523		<1%	67	$819.51
D1206	Topical application of fluoride varnish	<1%	3,505	$813.78
85240		<1%	84	$788.29
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	13,074	$775.62
82948		<1%	1,117	$770.51
82435		<1%	2,754	$769.12
86255		<1%	134	$752.29
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	43	$740.00
87493		<1%	25	$731.16
84166		<1%	223	$697.07
90384		<1%	14	$695.78
0031A		<1%	15	$659.48
82952		<1%	350	$650.90
87015		<1%	1,037	$649.99
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	81	$648.80
85460		<1%	27	$648.41
94761		<1%	89	$644.44
82397		<1%	117	$644.37
J1644	Injection, heparin sodium, per 1000 units	<1%	4,595	$635.00
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	41	$629.23
90630		<1%	16	$623.52
83993		<1%	16	$610.96
82247		<1%	1,472	$605.83
84134		<1%	120	$601.55
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	22,634	$597.25
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,702	$582.69
84295		<1%	2,745	$570.76
90658		<1%	79	$563.78
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,344	$544.69
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	73	$538.24
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	24	$531.32
84155		<1%	1,163	$530.10
87101		<1%	49	$517.87
76882		<1%	134	$516.09
86336		<1%	350	$511.15
84154		<1%	52	$505.88
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	938	$504.56
94200		<1%	138	$486.76
99417	Prolong home eval add 15m	<1%	50	$467.20
94626		<1%	49	$465.38
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	439	$459.18
86617		<1%	90	$458.59
0013A		<1%	12	$440.00
86316		<1%	126	$422.74
81267		<1%	15	$414.92
82040		<1%	271	$412.75
82310		<1%	552	$399.13
86922		<1%	15	$397.70
76826		<1%	15	$388.08
86618		<1%	119	$381.22
87640		<1%	208	$362.51
70360		<1%	374	$356.18
J0461	Injection, atropine sulfate, 0.01 mg	<1%	462	$338.66
82542		<1%	58	$332.83
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	6,791	$322.93
88173		<1%	92	$318.04
G1003	Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program	<1%	8,171	$314.95
82103		<1%	53	$307.45
82340		<1%	85	$299.87
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	11,806	$288.55
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,120	$280.70
73565		<1%	30	$277.35
72202		<1%	13	$271.21
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,859	$265.06
86364		<1%	306	$260.73
80178		<1%	241	$257.60
76828		<1%	15	$254.05
82787		<1%	52	$252.08
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	9,294	$251.42
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,399	$248.25
J9250	Methotrexate sodium, 5 mg	<1%	121	$239.24
84244		<1%	38	$219.55
82010		<1%	1,718	$208.67
90698		<1%	27	$206.11
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	148	$202.38
90648		<1%	23	$200.07
87075		<1%	178	$191.31
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	2,688	$190.57
86682		<1%	75	$186.69
82164		<1%	12	$181.48
80050	General health panel	<1%	16	$180.74
J0184	Injection, amisulpride, 1 mg	<1%	57	$179.21
90632		<1%	12	$177.54
86021		<1%	45	$176.06
82379		<1%	30	$174.47
82390		<1%	49	$173.65
83937		<1%	12	$169.26
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	29	$165.44
86778		<1%	96	$164.67
94760		<1%	199	$160.22
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	174	$157.03
J1630	Injection, haloperidol, up to 5 mg	<1%	2,625	$155.36
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,746	$142.47
84157		<1%	117	$141.12
84520		<1%	295	$140.06
J2060	Injection, lorazepam, 2 mg	<1%	2,635	$137.10
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	269	$131.30
81000		<1%	106	$130.40
84255		<1%	15	$128.81
82270		<1%	12	$117.26
J7070	Infusion, d5w, 1000 cc	<1%	394	$116.10
71100		<1%	83	$113.53
82945		<1%	130	$112.21
S4993	Contraceptive pills for birth control	<1%	165	$111.10
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	737	$109.48
J1940	Injection, furosemide, up to 20 mg	<1%	1,558	$104.15
15853		<1%	66	$100.00
80175		<1%	13	$95.26
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	13,953	$92.91
J2305	Injection, nitroglycerin, 5 mg	<1%	607	$87.84
82465		<1%	123	$81.15
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,141	$79.11
80187		<1%	37	$73.84
84478		<1%	34	$63.27
86702		<1%	15	$58.58
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	394	$56.39
J1953	Injection, levetiracetam, 10 mg	<1%	196	$55.90
87106		<1%	75	$53.78
86301		<1%	12	$51.75
J7510	Prednisolone oral, per 5 mg	<1%	1,784	$48.32
86701		<1%	15	$45.06
85300		<1%	12	$44.85
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	412	$43.95
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	128	$38.52
J7642	Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram	<1%	237	$37.60
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,666	$34.21
72074		<1%	25	$31.50
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	506	$30.28
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	136	$28.31
96373		<1%	16	$27.20
82365		<1%	39	$26.53
J3360	Injection, diazepam, up to 5 mg	<1%	225	$23.21
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	176	$21.45
72083		<1%	26	$20.43
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	490	$15.24
86308		<1%	153	$14.60
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	622	$10.68
J3411	Injection, thiamine hcl, 100 mg	<1%	364	$10.19
J1956	Injection, levofloxacin, 250 mg	<1%	270	$10.17
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	77	$9.30
D0220	Intraoral - periapical first radiographic image	<1%	1,111	$9.10
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	718	$8.57
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	<1%	60	$7.11
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	28	$6.79
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	30	$6.66
87176		<1%	29	$4.88
J1790	Injection, droperidol, up to 5 mg	<1%	93	$4.69
J3480	Injection, potassium chloride, per 2 meq	<1%	68	$3.33
84300		<1%	54	$3.10
84133		<1%	12	$2.64
S0028	Injection, famotidine, 20 mg	<1%	124	$1.07
J1171	Injection, hydromorphone, 0.1 mg	<1%	130	$0.38
91300		<1%	316	$0.34
J2470	Injection, pantoprazole sodium, 40 mg	<1%	44	$0.01
99080		0%	33,364	$0.00
D1120	Dental cleaning, child	0%	4,666	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	16	$0.00
D0330	Panoramic radiographic image	0%	76	$0.00
D0274	Bitewings - four radiographic images	0%	331	$0.00
J0153	Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)	0%	15	$0.00
D9430		0%	79	$0.00
D0145	Oral evaluation for a patient under three years of age	0%	12	$0.00
69210		0%	28	$0.00
D2391	Resin-based composite - one surface, posterior, primary or permanent	0%	19	$0.00
J0670	Injection, mepivacaine hydrochloride, per 10 ml	0%	12	$0.00
A9562	Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries	0%	12	$0.00
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	0%	17	$0.00
D0272	Bitewings - two radiographic images	0%	854	$0.00
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	0%	69	$0.00
D0230	Intraoral - periapical each additional radiographic image	0%	887	$0.00
76604		0%	39	$0.00
76010		0%	104	$0.00
D1208	Topical application of fluoride, excluding varnish	0%	1,186	$0.00
D1330		0%	38	$0.00
3E03329		0%	67	$0.00
D1310		0%	13	$0.00
77417		0%	31	$0.00
A4648	Tissue marker, implantable, any type, each	0%	13	$0.00
87147		0%	14	$0.00
J1805	Injection, esmolol hydrochloride, 10 mg	0%	14	$0.00
88331		0%	13	$0.00
D9310		0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBRESLIN, MICHAEL (GROUP SVP AND CFO)

Same official

Other billing entities under BRESLIN, MICHAEL

Full network →

Provider	Location	Paid
The New York and Presbyterian Hospital	New York, NY	$207.37M
Newyork-Presbyterian-Queens	Flushing, NY	$116.41M
New York and Presbyterian Hospital	Brooklyn, NY	$49.52M
The New York and Presbyterian Hospital	New York, NY	$6.29M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.